Status:
ACTIVE_NOT_RECRUITING
Rate Control in Patients With Atrial Fibrillation
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Atrial Fibrillation
Rate Control
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
To search for the best marker for the patients in atrial fibrillation with rate control
Detailed Description
In an aging society, the prevalence of atrial fibrillation is increasing. The main treatment strategy is to reduce the complications of embolic stroke and heart failure. Among these patients, a group ...
Eligibility Criteria
Inclusion
- 18\~90 years old
- Rate control is preferred after shared decision making
Exclusion
- cannot cooperate with or complete CPET
- has contraindication for CPET, such as uncontrolled heart failure, hypertension, angina, valvular heart disease, lung function impariment that SaO2\<90% at room air.
- Ventricular rate below 80/min before any medication
- Permanent pacemaker implanted
Key Trial Info
Start Date :
October 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04513509
Start Date
October 21 2020
End Date
December 31 2026
Last Update
July 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan